Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| MGCD-265 | MGCD-265. Group: Biochemicals. Alternative Names: N- [ [ [3-Fluoro-4- [ [2- (1-methyl-1H-imidazol-4-yl) thieno [3, 2-b] pyridin-7-yl] oxy] phenyl] amino] thioxomethyl] -benzeneacetamide. Grades: Highly Purified. CAS No. 875337-44-3. Pack Sizes: 5mg. Molecular Formula: C26H20FN5O2S2, Molecular Weight: 517.6. US Biological Life Sciences. |  Worldwide |
| MGCD-265 | MGCD-265 is a potent, multi-target and ATP-competitive inhibitor of c-Met and VEGFR1/2/3 with IC50 of 1 nM, 3 nM/3 nM/4 nM, respectively and also inhibits Ron and Tie2. Synonyms: MGCD-265; MGCD 265; MGCD265; MGCD-265-analog; MGCD 265-analog; MGCD265-analog. Glesatinib-analog. Grades: >98%. CAS No. 875337-44-3. Molecular formula: C26H20FN5O2S2. Mole weight: 517.60. |  |
| MGCD-265 analog | MGCD-265 analog is a potent and oral active inhibitor of c-Met and VEGFR2 tyrosine kinases, with IC 50 s of 29 nM and 10 nM, respectively. MGCD-265 analog has significant antitumor activity [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 875337-44-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-10991. |  |
| Glesatinib | Glasatinib (MGCD265) is a dual MET/SMO inhibitor. Glesatinib is a small molecule, multi-target tyrosine kinase inhibitor with potential anti-tumor activity, which can antagonize P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC). Synonyms: MGCD-265; MGCD 265; MGCD265. Grades: ≥98% by HPLC. CAS No. 936694-12-1. Molecular formula: C31H27F2N5O3S2. Mole weight: 619.7. | |
| Glesatinib hydrochloride | The hydrochloride salt form of Glesatinib, an inhibitor of tyrosine kinase, could be effectively targeting tumors that are driving to grow through MET and AXL receptor. It seems to be more common in non-small cell lung cancer and it is still under Phase I. Uses: The hydrochloride salt form of glesatinib could be effectively targeting tumors that are driving to grow through met and axl receptor. Synonyms: MGCD265 hydrochloride; MGCD-265 hydrochloride; MGCD 265 hydrochloride. Grades: 98%. CAS No. 1123838-51-6. Molecular formula: C31H27ClF2N5O3S2X. Mole weight: 655.16. | |
Our database is helping our users find suppliers everyday.
